ATC code C08

ATC codes
C Cardiovascular system
	C01 Cardiac therapy
	C02 Antihypertensives
	C03 Diuretics
	C04 Peripheral vasodilators
	C05 Vasoprotectives
	C07 Beta blocking agents
	C08 Calcium channel blockers
	C09 Agents acting on the renin–angiotensin system
	C10 Lipid modifying agents
A B C D G H QI J L M N P R S V ; (Hover over links to see titles) ;

ATC code C08 Calcium channel blockers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.^[1]^[2] Subgroup C08 is part of the anatomical group C Cardiovascular system.^[3]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QC08.^[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

C08C Selective calcium channel blockers with mainly vascular effects

C08CA Dihydropyridine derivatives

C08CA01 Amlodipine

C08CA02 Felodipine

C08CA03 Isradipine

C08CA04 Nicardipine

C08CA05 Nifedipine

C08CA06 Nimodipine

C08CA07 Nisoldipine

C08CA08 Nitrendipine

C08CA09 Lacidipine

C08CA10 Nilvadipine

C08CA11 Manidipine

C08CA12 Barnidipine

C08CA13 Lercanidipine

C08CA14 Cilnidipine

C08CA15 Benidipine

C08CA16 Clevidipine

C08CA55 Nifedipine, combinations

C08CX Other selective calcium channel blockers with mainly vascular effects

C08CX01 Mibefradil

C08D Selective calcium channel blockers with direct cardiac effects

C08DA Phenylalkylamine derivatives

C08DA01 Verapamil

C08DA02 Gallopamil

C08DA51 Verapamil, combinations

C08DB Benzothiazepine derivatives

C08DB01 Diltiazem

C08E Non-selective calcium channel blockers

C08EA Phenylalkylamine derivatives

C08EA01 Fendiline

C08EA02 Bepridil

C08EX Other non-selective calcium channel blockers

C08EX01 Lidoflazine

C08EX02 Perhexiline

C08G Calcium channel blockers and diuretics

C08GA Calcium channel blockers and diuretics

C08GA01 Nifedipine and diuretics

C08GA02 Amlodipine and diuretics

References

↑ ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.
↑ ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.
↑ ATC/DDD Index 2022
code C08(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.
↑ ATCvet Index 2022
code QC08(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

Lua error in package.lua at line 80: module 'strict' not found.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP-1 injections from $125.

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

[1] ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). {{{website}}}. National Institutes of Health.

[2] ATC-Klassifikation mit definierten Tagesdosen DDD(link). {{{website}}}. German Institute for Medical Documentation and Information.

[3] ATC/DDD Index 2022
code C08(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

[4] ATCvet Index 2022
code QC08(link).
{{{website}}}. WHO Collaborating Centre for Drug Statistics Methodology.

[1]

[2]

[3]

[4]